ID

24566

Description

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Keywords

Versions (1)
  1. 8/6/17 8/6/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 6, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Hepatitis A Vaccine Month 138 Visit 18 FOLLOW-UP STUDIES NCT00291876

English

GSK Hepatitis A Vaccine Month 138 FOLLOW-UP STUDIES NCT00291876

1 forms  
Study administration
Description

Study administration

Center
Description

Center

Data type

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Description

Date of Visit

Data type

date

Alias
UMLS CUI [1]
C1320303
Subject Number
Description

Subject Identifier

Data type

integer

Alias
UMLS CUI [1]
C2348585
FOLLOW-UP STUDIES
Description

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Description

Follow Up Status

Data type

boolean

Alias
UMLS CUI [1]
C0589120
If No, please specify reason: Adverse Events, or Serious Adverse Events: please specify:
Description

adverse event

Data type

text

Alias
UMLS CUI [1]
C0877248
If No, please specify reason: Other: please specify:
Description

other reason

Data type

text

Alias
UMLS CUI [1]
C3840932
Back to the top of the page

Similar models

GSK Hepatitis A Vaccine Month 138 FOLLOW-UP STUDIES NCT00291876

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
FOLLOW-UP STUDIES
Follow Up Status
Item
Would the subject be willing to participate in a follow-up study?
boolean
C0589120 (UMLS CUI [1])
adverse event
Item
If No, please specify reason: Adverse Events, or Serious Adverse Events: please specify:
text
C0877248 (UMLS CUI [1])
other reason
Item
If No, please specify reason: Other: please specify:
text
C3840932 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial